Skip to main content

Advertisement

Log in

Outcomes of a Cancer Clinical Trial Matching Service

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

Abstract

The American Cancer Society (ACS) and Coalition of Cancer Cooperative Groups (CCCG) provide a clinical trial (CT) information/matching/eligibility service (Clinical Trials Matching Service [CTMS]). Patients' demographic and clinical data, enrollment status, and self-reported barriers to CT participation were analyzed to assess enrollment rates and determinants of enrollment. During 3 years beginning October 1, 2007, the CTMS served 6,903 patients via the ACS call center. Among the 1,987 patients with follow-up information on enrollment, 219 (11.0%) enrolled in a CT; 48 of these 219 enrollees chose a CT they found via the CTMS. Patients were less likely to enroll if they had poor ECOG performance status (P = 0.032); were African American (P = 0.0003), were uninsured or had Medicaid coverage (P = 0.024), or had lower stage disease (P = 0.018). Enrollment varied by trial type/cancer site/system (P = .026). Several barriers significantly predicted nonenrollment. Broader availability of a CTMS might help improve patient participation in cancer clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Institute of Medicine (2010) A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. National Academies Press, Washington, DC

    Google Scholar 

  2. Dugas M, Amler S, Lange M, Gerss J, Breil B, Kopcke W (2009) Estimation of patient accrual rates in clinical trials based on routine data from hospital information systems. Methods Inf Med 48:263–6

    Article  PubMed  Google Scholar 

  3. Scott R, Scoggins J (2008) Practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist 13:925–9

    Article  Google Scholar 

  4. Gregory CA, Chabner BA (2008) One in five cancer clinical trials is published: A terrible symptom—what's the diagnosis? Oncologist 13:923–4

    Article  Google Scholar 

  5. Institute of Medicine (2008) Improving the quality of cancer clinical trials: Workshop summary. National Academies Press, Washington, DC

    Google Scholar 

  6. Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilburt J, Gibbons MC, Baffi C, Wilson RF, Feuerstein CJ, Tanpitukpongse P, Powe NR, Bass EB (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment No 05-E019-2. Prepared by the Johns Hopkins University Evidence-based Practice Center, Baltimore MD

  7. Comis RL, Aldigé CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ (2000) A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials. http://www.cancertrialshelp.org/CTHpdf/308-9.pdf

  8. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830–835

    Article  PubMed  Google Scholar 

  9. Coalition of Cancer Cooperative Groups (July 2006) The clinical trial awareness gap: Coalition study reveals high satisfaction, low participation. Clinical Trial Matters. http://www.cancertrialshelp.org/CTHpdf/newsletterjuly2006.pdf. Accessed May 28, 2010

  10. Umutyan A, Chiechi C, Beckett LA, Paterniti DA, Turrell C, Gandara DR, Davis SW, Wun T, Chen MS Jr, Lara PN Jr (2008) Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign. Cancer 112(1):212–9

    Article  PubMed  Google Scholar 

  11. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–55

    Article  PubMed  CAS  Google Scholar 

  12. Commission on Cancer. Public Benchmark Reports, Cases Diagnosed 2000–2008. http://cromwell.facs.org/BMarks/BMPub/Ver10/bm_reports.cfm. Accessed December 1, 2010

  13. Meropol NJ, Buzaglo JS, Millard J, Damjanov N, Miller SM, Ridgway C, Ross EA, Sprandio JD, Watts P (2007) Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw 5:655–64

    PubMed  Google Scholar 

  14. Siegel R, Ward E, Brawley O, Jemal A (2010) Cancer statistics, 2010. CA Cancer J Clin 61:212–36

    Article  Google Scholar 

  15. Baquet CR, Commiskey P, Mullins CD, Mishra SI (2006) Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 30(1):24–33

    Article  PubMed  Google Scholar 

  16. Park ER, Weiss ES, Moy B (2007) Recruiting and enrolling minority patients to cancer clinical trials. J Community Oncol 4:254–7

    Google Scholar 

  17. Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720–6

    Article  PubMed  CAS  Google Scholar 

  18. Lara PN Jr, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A, Martel CL, Gandara DR, Wun T, Beckett LA, Chen MS Jr (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23(36):9282–9

    Article  PubMed  Google Scholar 

  19. Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, Hamilton AS (2001) Comparison of self-reported initial treatment with medical records: Results from the Prostate Cancer Outcomes Study. Am J Epidemiol 154:582–7

    Article  PubMed  CAS  Google Scholar 

  20. Phillips K-A, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MRE, Giles GG, Hopper JL (2005) Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol 23(21):4679–86

    Article  PubMed  Google Scholar 

  21. Klabunde CN, Keating NL, Potosky AL, Ambs A, Hei Y, Hornbrook MC, Ganz PA (2011) A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst 103(5):384–97

    Article  PubMed  Google Scholar 

  22. Metz JM, Coyle C, Hudson C, Hampshire M (2005) An Internet-based cancer clinical trials matching resource. J Med Internet Res 7(3):e24

    Article  PubMed  Google Scholar 

  23. Atkinson NL, Saperstein SL, Massett HA, Leonard CR, Grama L, Manrow RR (2008) Using the Internet to search for cancer clinical trials: a comparative audit of clinical trial search tools. Cont Clin Trials 29(4):555–64

    Article  Google Scholar 

  24. Simon C, Hegedus S (2005) Exploring websites on cancer clinical trials: an empirical review. Cont Clin Trials 26:530–3

    Article  Google Scholar 

  25. Moffitt K, Brogan F, Brown C, Kasper M, Rosenblatt J, Smallridge R, Sullivan D, Kromrey J (2010) Statewide cancer clinical trial navigation service. J Oncol Pract 6:127–32

    Article  PubMed  Google Scholar 

Download references

Funding and Financial Disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ted Gansler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gansler, T., Jin, M., Bauer, J. et al. Outcomes of a Cancer Clinical Trial Matching Service. J Canc Educ 27, 11–20 (2012). https://doi.org/10.1007/s13187-011-0296-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-011-0296-x

Keywords

Navigation